immune system diseases
HTG to Expand Disease Reach With New Whole-Transcriptome Profiling Product Mid-2021
The firm aims to launch an early-access program by the end of the year, followed by a second white paper before the JP Morgan Healthcare Conference in January.Â
Exagen Q3 Revenues Rise 4 Percent Despite COVID-19 Pandemic Challenges
The firm attributed lower year-over-year Q3 testing volumes to COVID-19 impacts and a decrease in average reimbursement per test.
Blueprint Genetics, NICER Consortium Developing Genetic Test for Immunologic, Hematologic Disorders
Blueprint Genetics, recently acquired by Quest Diagnostics in January, will base the 600-gene panel on its whole-exome sequencing capability.
Multi-Disease Diagnostic Platform Project Receives €22.5M in EU Funding
An international group of researchers aim to develop an approach that may be able to diagnose multiple conditions, including pneumonia, tuberculosis, sepsis, with one blood sample.
ProciseDx, Lumiphore Ink Partnership for Rapid Point-of-Care Tests
ProciseDx anticipates bringing rapid, quantitative point-of-care tests to market in 2020 using Lumiphore's metal luminescent reporter technology.